Supporting this possibility is the finding that pharmacologic inhibition of PERK protects against DPR aggregation and neurotoxicity in both fly and mouse models of C9orf72-ALS [130]. The gene discussed is EIF2AK3; the disease is amyotrophic lateral sclerosis.